RE:ASTONISHINGThey were planning for a total of 1.5M, they now have that. Combined with the 1.3M they have raised prior, Voyageur is well postioned to advance their strategic planning into production. It may be in their best interests to cease their capital raising now. Summer months have been historically hum drum for the market. This could dip down to a dime.
I do expect plenty of good news in 4th quarter this year. FDA approval will send this stock significantly higher. To many people worried about pennies when this stock is headed into the dollars if management can execute their strategic planning. Outside of China, this is the only medical grade barium sulphate mine in the world. Further, I do not trust anything made in China as there is well documented cases of ingredient fraud, safety standards violations and government cohersion. Voyageur will quickly be the "go to' barium sulphate company in the medical community.
Value added with their two industrial barium sulphate mines and advancing their iodine plans will triple their revenue.I believe long holders will be greatly rewarded.